Cormorant Asset Management, LLC

Average Profitability
<0.0001%
Insider Buys Quantity
20
Insider Buys Sum
$274.75M
Insider Sells Quantity
3
Insider Sells Sum
$3.91M

Insider Activity of Cormorant Asset Management, LLC

According to the SEC Form 4 filings, Cormorant Asset Management, LLC, being in a position of

  1. 10 percent owner at EyePoint Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 4794057 shares for $89.5M, and sold 0 shares,
    over all time since 2023-12-04, has bought 4794057 shares for $89.5M, and sold 0 shares.

The largest purchase of all time was on 2023-12-04 and amounted to 1919057 shares of EyePoint Pharmaceuticals, Inc. for $41.87M.

The largest sale of all time was on 2024-03-14 and amounted to 509091 share of Immuneering Corporation for $1.89M.

Biography of Cormorant Asset Management, LLC

No biography is available at this moment.

2024-05-06PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
850,000
1.8064%
$11.86$10.08M-18.28%
2024-04-18PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
581,765
1.2029%
$18.03$10.49M-47.11%
2024-04-01SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.4407%
$2.90$1.16M-43.27%
2024-03-15SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.5312%
$2.14$856,400-16.23%
2024-03-14SaleImmuneering Corporation
IMRX
10 percent owner
509,091
1.0954%
$3.72$1.89M-44.48%
2024-01-11PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
750,000
2.0594%
$19.75$14.81M-43.33%
2024-01-09PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
105,000
0.2958%
$21.32$2.24M-45.81%
2023-12-08PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
588,235
1.4847%
$17.00$10M-35.79%
2023-12-04PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
1.92M
6.3418%
$21.82$41.87M-35.79%
2021-10-25PurchaseVentyx Biosciences, Inc.
VTYX
1.25M
8.2073%
$16.00$20M-16.24%
2021-10-13PurchasePyxis Oncology, Inc.
PYXS
450,000
1.9034%
$16.00$7.2M-70.72%
2021-09-17PurchaseTyra Biosciences, Inc.
TYRA
625,000
5.4808%
$16.00$10M-43.6%
2021-08-03PurchaseImmuneering Corporation
IMRX
550,000
2.3534%
$15.00$8.25M-47.84%
2021-07-02PurchaseAerovate Therapeutics, Inc.
AVTE
1M
2.9395%
$14.00$14M-34%
2021-06-29PurchaseElevation Oncology, Inc.
ELEV
250,000
30.0099%
$16.00$4M-56%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
600,000
11.7588%
$19.00$11.4M-7.95%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
550,000
3.5535%
$19.00$10.45M-7.41%
2021-03-30PurchaseDesign Therapeutics, Inc.
DSGN
750,000
2.8822%
$20.00$15M-40.99%
2020-12-18PurchaseBioAtla, Inc.
BCAB
1.6M
2.4444%
$18.00$28.8M+17.46%
2020-11-23PurchaseOlema Pharmaceuticals, Inc.
OLMA
850,000
1.5181%
$19.00$16.15M-44.3%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.